2016
DOI: 10.1186/s13567-016-0399-9
|View full text |Cite
|
Sign up to set email alerts
|

Heterogeneous antigenic properties of the porcine reproductive and respiratory syndrome virus nucleocapsid

Abstract: Porcine reproductive and respiratory syndrome virus (PRRSV) is an arterivirus responsible for a widespread contagious disease of domestic pigs with high economic impact. Switzerland is one of the rare PRRSV-free countries in Europe, although sporadic outbreaks have occurred in the past. The PRRSV isolate IVI-1173 from the short outbreak in Switzerland in 2012 was entirely sequenced, and a functional full-length cDNA clone was constructed. Genetic and antigenic characterization of IVI-1173 revealed the importan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 61 publications
0
10
0
Order By: Relevance
“…This change in host resources can then lead to changes in the metabolism of the host that eventually disrupts the proper activation of monocytic cells such as macrophages, allowing the virus to proceed unimpeded by the host cytokines (Langston et al, 2017) toward entry and proliferation. In a 2016 paper, Rappe et al (2016) was able to observe that PRRS type 1 and 2 virus nucleocapsids can contain an amino acid substitution that replaces a threonine with alanine causing the PRRS virus strain in that study to escape immune system protection. Therefore, it is possible that the virus is promoting differential expression of host alanine as a means of both hijacking needed nutrients and avoiding detection by innate immunity.…”
Section: Discussionmentioning
confidence: 99%
“…This change in host resources can then lead to changes in the metabolism of the host that eventually disrupts the proper activation of monocytic cells such as macrophages, allowing the virus to proceed unimpeded by the host cytokines (Langston et al, 2017) toward entry and proliferation. In a 2016 paper, Rappe et al (2016) was able to observe that PRRS type 1 and 2 virus nucleocapsids can contain an amino acid substitution that replaces a threonine with alanine causing the PRRS virus strain in that study to escape immune system protection. Therefore, it is possible that the virus is promoting differential expression of host alanine as a means of both hijacking needed nutrients and avoiding detection by innate immunity.…”
Section: Discussionmentioning
confidence: 99%
“…The mutations (V88F, M94I, F95L) were individually introduced by the Q5 Site-Directed Mutagenesis Kit (New England Biolab, Ipswich, MA, USA) in the plasmid clone, pIVI-1173 [38] containing the full-length cDNA of the infectious genome of the PRRSV1 IVI-1173 strain [GenBank: KX622783]. Primers were designed through NEBaseChanger () (Table 1).…”
Section: Methodsmentioning
confidence: 99%
“…Briefly, MARC-145 cells were infected with wild-type and mutant variants at a MOI of 0.1. After 1 and 12 h post-infection (hpi), cells were fixed with ice cold (−20 °C) methanol prior to immunofluorescence staining with primary monoclonal antibodies 13E2 against PRRSV nucleocapsid protein (IgG2a, 1:50) [38]. As control, 1C11 against gB of PrV (IgG2a, 1:50) was used as isotype matched irrelevant antibody [42].…”
Section: Methodsmentioning
confidence: 99%
“…A cDNA sequence corre s ponding to the entire BoAstV-CH13 reference genome (GenBank accession number NC_024498.1) was synthesized and cloned by a commercial service (Eurofins) in two fragments: pJET_BoAstV-CH13_Frag A, and pGH_BoAstV-CH13_Frag B. Both fragments were linked by Gibson PCR and cloned into the low copy plasmid pACJR 20 (kindly provided by N. Ruggli, Institute of Virology and Immunology, Mittelhäusern, Switzerland) resulting in the construct pACJR_BoAstV-CH13-#55. The sequence was flanked by a T7 promoter sequence at the 5′ end and a unique SwaI site at the 3′ end.…”
Section: Methodsmentioning
confidence: 99%